Tricuspid Valve Operations


Surgical Anatomy

  • The tricuspid valve is located between the right atrium (RA) and right ventricle and has a valve area of 4 to 6 cm. The tricuspid valve is composed of three leaflets—the anterior, posterior, and septal. The leaflets are supported by chordae tendineae and papillary muscles. Compared with the mitral valve, the leaflets and chordae tendineae of the tricuspid valve are thinner and the tricuspid orifice is larger and more triangular.

  • The anterior leaflet is the largest of the three leaflets and extends through the anterior portion of the annulus. Its chordae attach to the anterior and septal papillary muscles. The posterior leaflet is the smallest leaflet and extends through the inferior and posterior edges of the annulus; its chordae originate from the posterior and anterior papillary muscles. The septal leaflet is the most medial and is attached directly to the interventricular septum; it is larger than the posterior leaflet, and its chordae attach to the posterior and septal papillary muscles. The septal leaflet is relatively immobile due to its attachment to the fibrous structure of the heart.

  • The tricuspid valve is a continuous veil of thin fibrous tissue. Three commissures are delineated by fan-shaped chordae of the three leaflets:

    • Anteroseptal commissure—where the basal attachment of the tricuspid valve reaches its highest level at the membranous interventricular septum and where the anterior and septal walls of the right ventricle join

    • Anteroposterior commissure—forms a deep indentation in the leaflet tissue between the anterior and posterior leaflets

    • Posteroseptal commissure—a deep indentation in the leaflet tissue at the junction of the posterior and septal walls of the right ventricle.

Tricuspid Valve Annulus

  • The tricuspid valve annulus is part of the fibrous skeleton of the heart. It consists of a ring of collagenous tissue that generally extends around the line of attachment of the leaflets of the tricuspid valve. It is very thin and difficult to identify. The tricuspid annulus is a complex three-dimensional (3D) structure; the normal tricuspid valve annulus is saddle-shaped, with the highest points located in an anteroposterior orientation and the lowest points at the area of the septal leaflet. With the development of functional tricuspid regurgitation (TR), changes in the 3D annular shape lead to loss of the saddle shape and more flattening of the annulus; that is, the tricuspid annulus becomes dilated and more planar and circular and hence, restoration of the 3D shape of the annulus may be an important therapeutic goal beyond that of annular reduction alone.

  • Normal tricuspid valve annulus diameter in adults is 28 ± 5 mm in the four-chamber view. Significant tricuspid annular dilation is defined by a diastolic diameter of more than 21 mm/m 2 (> 35 mm).

Relation of the Tricuspid Valve to Other Structures

  • Structures surrounding the tricuspid valve that are of major surgical significance include the coronary sinus, atrioventricular (AV) node, membranous septum, bundle of His, and right coronary artery ( Fig. 23.1 ).

    Figure 23.1, (A and B) Anatomy and relations of tricuspid valve.

  • The conduction system is near the septal leaflet and its anterior septal commissure. The AV node lies in the atrial septum bordering the septal leaflet, superior and anterior to the coronary sinus. Its exact location can be approximated at the apex of the triangle of Koch, a triangle composed of the septal annulus and tendon of Todaro as its sides and the coronary sinus orifice as its base. Extending from the AV node is the bundle of His, which penetrates the right trigone under the interventricular component of the membranous septum (≈ 5 mm inferior to the anterior septal commissure) and runs along the crest of the muscular septum. The membranous septum usually lies beneath the septal leaflet inferior to the anterior septal commissure. The right coronary artery runs anterior to the anterior leaflet annulus and may be injured by deep sutures in the annulus.

Preoperative Considerations

Causes of Tricuspid Valve Diseases

Tricuspid Stenosis

  • This is usually rheumatic in origin. On rare occasions, infective endocarditis, congenital abnormalities, or carcinoid disease may be implicated. Rheumatic tricuspid involvement usually results in both tricuspid stenosis and regurgitation, and it typically coexists with mitral or aortic rheumatic disease. The hallmark features of rheumatic tricuspid stenosis are commissural fusion and leaflet thickening, but calcification is usually absent. Carcinoid syndrome leads to focal or diffuse deposits of fibrous tissue on the endocardium of the valve leaflets and cardiac chambers. The tricuspid valve in carcinoid syndrome is thickened, with retracted leaflets fixed in a semiopen position, resulting in both tricuspid stenosis and regurgitation, and usually not amenable for repair.

Tricuspid Valve Regurgitation

  • TR can occur with abnormal or normal valve leaflets. Causes of TR associated with abnormalities of the tricuspid leaflets include rheumatic valve disease, endocarditis, carcinoid syndrome, radiation therapy, Marfan syndrome, papillary muscle dysfunction, and congenital disorders such as Ebstein anomaly. Penetrating and nonpenetrating trauma, iatrogenic damages during cardiac surgery, biopsies, catheter placement in right heart chambers, and placement or extraction of pacemakers and defibrillator leads are also rare causes of TR.

Degenerative Tricuspid Regurgitation

  • Tricuspid prolapse is generally associated with mitral valve prolapse and is defined as a midsystole posterior leaflet displacement beyond the annular plane. The coaptation line is above the annular plane. Tricuspid prolapse usually involves more than one leaflet, and often the three leaflets are affected. The most common phenotype of tricuspid prolapse is diffuse myxomatous degeneration (Barlow disease). A flail tricuspid leaflet is observed when the free edge of a leaflet is completely reversed in the RA, usually as a consequence of ruptured chordae. It also is common in infective endocarditis in association with vegetations.

Secondary Tricuspid Regurgitation

  • Approximately 80% of cases of significant TR are functional in nature. Regurgitation develops with normal tricuspid valve leaflets as a result of right ventricular (RV) dysfunction and tricuspid annular dilation (functional regurgitation), usually in the context of left-sided valvular disease. Pulmonary hypertension or RV dysfunction leads to elevations of RV systolic and diastolic pressures, RV cavity enlargement, and tricuspid annular dilation. The circumference of the tricuspid annulus lengthens primarily along the attachments of the anterior and posterior leaflets. The septal leaflet portion, on the other hand, is fixed between the right and left trigones and the atrial and ventricular septa, preventing its lengthening. As annular and ventricular dilation progress, the cordal–papillary muscle complex becomes functionally shortened, with tethering of the leaflets, although it remains normal in appearance. This combination of RV enlargement and tricuspid annular dilation prevents leaflet coaptation and leads to valvular incompetence ( Fig. 23.2 ).

    Figure 23.2, Triscupid valve annulus mode of dilation.

  • Previously, it was believed that functional TR decreased or even disappeared after surgical correction of left-sided valve disease. This concept influenced cardiac surgery practice for many years. More experience, however, has led to better appreciation of the potential for progression of functional TR and tricuspid annular dilation after left-sided surgery. This effect may occur in spite of the complete correction of the mitral and aortic disease and the resolution of pulmonary hypertension after surgery. Tricuspid annular dilation is the strongest and most consistent risk factor for the development of late TR after left-sided valve surgery.

  • Severe TR and its resultant RV dysfunction and venous congestion contribute to an increase in early and late morbidity and mortality after left-sided valve surgery. Moreover, reoperation to correct worsening postoperative TR is associated with a high operative mortality rate and disappointing long-term results. Therefore, a proactive strategy of prophylactic repair of a dilated tricuspid annulus at the time of the initial left-sided valve surgery, regardless of the degree of TR, has been advocated as a strategy to help reduce the incidence of late TR and RV failure and the complexity and higher risk of redo surgery. Concomitant mitral and tricuspid valve repair is associated with significant RV reverse remodeling and improvement in functional class postoperatively.

Assessment of the Tricuspid Valve

  • Imaging of the tricuspid valve is a challenging process. Functional TR is dynamic in nature, so the degree of severity of TR may change, especially under general anesthesia, and the decision for tricuspid valve intervention should be made before surgery based on preoperative echocardiography and careful clinical assessment of the patient.

  • Tricuspid valve analysis can be achieved with two-dimensional (2D)–transthoracic echocardiography (TTE) imaging (the technique of choice). 3D-TTE can be used as an additive approach. Transesophageal echocardiography (TEE) is advised in case of suboptimal TTE images to evaluate the severity of TR. TTE helps determine cause, measures the size of right-sided chambers and the inferior vena cava (IVC), assesses RV systolic function, estimates pulmonary artery systolic pressure, and characterizes any associated left-sided heart disease. TEE describes the morphology and pathophysiology of the tricuspid valve and grades the severity of tricuspid valve regurgitation. It is of note that TEE usually underestimates the measurement of the tricuspid valve annulus. The evaluation of tricuspid valve annulus dilation is a matter of ongoing controversy and is less precise compared with mitral valve annulus assessment.

  • Cardiovascular magnetic resonance (CMR) is another imaging modality for the tricuspid valve that allows visualization of the anatomy and function of the tricuspid valve. It also permits quantification of the regurgitant volume and regurgitant fraction.

Indications for Tricuspid Valve Intervention

  • The 2014 American College of Cardiology/American Heart Association valve guidelines has indicated the following recommendations:

    • 1.

      Tricuspid valve repair for patients with severe functional TR who are undergoing concurrent surgery for mitral valve disease (Class I, level of evidence C).

    • 2.

      Tricuspid valve intervention for severe primary TR in symptomatic patients (Class IIa, level of evidence C). When the tricuspid valve leaflets are too diseased and not amenable to repair, tricuspid valve replacement is believed to be reasonable for patients with severe TR.

    • 3.

      Tricuspid valve repair may be considered for less than severe TR in patients undergoing mitral valve surgery in the presence of pulmonary hypertension or tricuspid annular dilation (Class IIa, level of evidence B).

    • 4.

      Tricuspid valve repair may be considered for patients with moderate functional TR and pulmonary artery hypertension at the time of left-sided valve surgery (Class IIa, level of evidence C).

    • 5.

      Tricuspid valve surgery may be considered for asymptomatic or minimally symptomatic patients with severe primary TR and progressive degree of moderate or greater RV dilation and/or systolic dysfunction (Class IIa, level of evidence C).

    • 6.

      Reoperation for isolated tricuspid valve repair or replacement may be considered for persistent symptoms due to severe TR in patients who have undergone previous left-sided valve surgery and who do not have severe pulmonary hypertension or significant RV systolic dysfunction (Class IIa, level of evidence C).

  • American College of Cardiology/American Heart Association practice guidelines have recommended against tricuspid surgery for patients with only mild primary TR. Tricuspid surgery is also not indicated for patients with some degree of TR who are asymptomatic, when there is no concurrent left-sided valve disease, or when severe pulmonary hypertension is absent.

  • Several cardiac surgery centers currently advocate for the routine repair of the dilated tricuspid annulus at the time of left-sided heart surgery, regardless of the degree of TR. At our center, we consider valve repair even if there is no associated TR or only a mild degree of TR when the tricuspid annulus diameter is 40 mm or more with the presence of pulmonary hypertension (PH; defined as a mean pulmonary artery pressure ≥25 mm Hg at rest) or 45 mm or more in the absence of PH. Such repair could reduce the risk of RV dysfunction, both in the perioperative period and in the long term, as well as the need for a second operation ( Table 23.1 ).

    Table 23.1
    Indications for tricuspid valve surgery
    CLASS TRICUSPID VALVE SURGERY LEVEL OF EVIDENCE
    TRICUSPID VALVE REGURGITATION
    Tricuspid valve surgery is recommended for patients with severe tricuspid regurgitation (TR; symptomatic or nonsymptomatic) undergoing left-sided valve surgery. Tricuspid valve repair can be beneficial for patients with mild, moderate, or greater functional TR at the time of left-sided valve surgery with tricuspid annular dilation or prior evidence of right heart failure. C
    I Tricuspid valve surgery can be beneficial for patients with symptoms due to severe primary TR that are unresponsive to medical therapy. B
    IIa Tricuspid valve repair may be considered for patients with moderate functional TR and pulmonary artery hypertension at the time of left-sided valve surgery.
    Tricuspid valve surgery may be considered for asymptomatic or minimally symptomatic patients with severe primary TR and progressive degrees of moderate or greater right ventricular (RV) dilation and/or systolic dysfunction.
    C
    IIb Reoperation for isolated tricuspid valve repair or replacement may be considered for persistent symptoms due to severe TR in patients who have undergone previous left-sided valve surgery and who do not have severe pulmonary hypertension or significant RV systolic dysfunction. C
    TRICUSPID VALVE STENOSIS
    I Tricuspid valve surgery is recommended for patients with severe tricuspid stenosis (TS) at the time of operation for left-sided valve disease. Tricuspid valve surgery is recommended for patients with isolated, symptomatic, severe TS. C
    IIb Percutaneous balloon tricuspid commissurotomy might be considered in patients with isolated tricuspid severe tenosis C

  • Functional TR in association with aortic stenosis may persist or even become progressive after aortic valve replacement alone; it is usually associated with left ventricular (LV) diastolic dysfunction. A concomitant tricuspid valve procedure should be considered in select patients with aortic stenosis at the time of aortic valve replacement.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here